Proposed mechanisms include sex hormone receptor expression (particularly progesterone receptors) in many meningiomas, in contrast to the molecular pathways—such as RB inactivation and immune modulation—implicated in aggressive gliomas favoring male patients [27]. The gene discussed is RB1; the disease is meningioma.